Hazem A. Mahdy - Concepedia

Author

Hazem A. Mahdy

Also Known As

H. A. Mahdy, H. Mahdy, Hazem A Mahdy, Hazem A. Mahdy, Hazem Mahdy, Hazem.A. Mahdy, Husayn Al Mahdy, Mahdy, H., Mahdy, Hazem A.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Almaarefa University Princess Nourah bint Abdulrahman University Alfaisal University Cairo University

About

Hazem A. Mahdy is an author at Al-Azhar University specializing in medicinal chemistry, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	973
2	Biomolecular Engineering	7	7	405
3	Engineering	1	1	67
4	Natural Sciences	1	1	22
5	Biochemistry	1	1	22

Hazem A. Mahdy

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers Hazem A. Mahdy, M.K. Ibrahim, Ahmed M. Metwaly, Bioorganic Chemistry Medicinal ChemistryNovel TherapyMedicineAnticancer EvaluationPotential Vegfr-2 Inhibitors	2019	163
Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR<sup>WT</sup>and EGFR<sup>T790M</sup> Ahmed Abdel Nasser, Ibrahim H. Eissa, Mohamed R. Oun, Organic & Biomolecular Chemistry	2020	118
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy, Journal of Enzyme Inhibition and Medicinal Chemistry	2021	118
Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents Souad A. El‐Metwally, Mohsen M. Abou-El-Regal, Ibrahim H. Eissa, Bioorganic Chemistry Anti-cancer AgentsMedicinal ChemistryMedicineDrug DiscoveryRational Drug Design	2021	111
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi, Bioorganic Chemistry Medicinal ChemistryNew Quinoxaline DerivativesMedicineVegfr-2 InhibitorsPharmacotherapy	2021	104
New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation Mohammed M. Alanazi, Hazem A. Mahdy, Nawaf A. Alsaif, Bioorganic Chemistry Molecular PharmacologyMedicinal ChemistryDiversity Oriented SynthesisMedicineVegfr-2 Inhibitors	2021	96
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicineAnti-proliferative EvaluationPotential Vegfr-2 InhibitorsAnti-cancer Agent	2020	91
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma Ibrahim H. Eissa, M.K. Ibrahim, Ahmed M. Metwaly, Bioorganic Chemistry Medicinal ChemistryMedicineVegfr-2 InhibitorsPharmacologyAnti-cancer Agent	2020	91
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation Ibrahim H. Eissa, Abdel‐Ghany A. El‐Helby, Hazem A. Mahdy, Bioorganic Chemistry Medicinal ChemistryMedicineDrug DiscoveryVegfr-2 InhibitorsRational Drug Design	2020	85
Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors Ibrahim H. Eissa, Ahmed M. Metwaly, Amany Belal, Archiv der Pharmazie	2019	72

Page 1